- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VENUS CONCEPT Aktie jetzt für 0€ handeln | |||||
| 13.05. | Venus Concept Inc.: Venus Concept Announces Senior Management Changes | 157 | GlobeNewswire (Europe) | TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global medical aesthetic technology leader, today announced changes to its senior leadership team.... ► Artikel lesen | |
| 01.04. | Venus Concept Inc.: Venus Concept Announces Completion of Common Stock Sale and Short-Form Merger | 180 | GlobeNewswire (Europe) | TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global medical aesthetic technology leader, today announced the successful completion by affiliates... ► Artikel lesen | |
| 09.02. | Venus Concept Inc. - 15-12G, Securities registration termination | 1 | SEC Filings | ||
| 03.02. | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.01. | Venus Concept Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 2 | SEC Filings | ||
| 21.01. | Why Is Venus Concept Stock Plunging Today? | 3 | Benzinga.com | ||
| 21.01. | Venus Concept to voluntarily delist from Nasdaq and deregister with SEC; shares tumble | 5 | Seeking Alpha | ||
| 21.01. | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.01. | Venus Concept Inc.: Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC | 230 | GlobeNewswire (Europe) | TORONTO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") announced today its voluntarily decision to delist its common stock from the NASDAQ Capital Market... ► Artikel lesen | |
| 16.01. | Venus Concept Stock Explodes Over 500% After Major Investor Takes Control | 37 | Benzinga.com | ||
| 13.11.25 | Venus Concept Inc.: Venus Concept Announces Third Quarter 2025 Financial Results | 465 | GlobeNewswire (Europe) | TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen | |
| 10.11.25 | Venus Concept Inc.: Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments | 374 | GlobeNewswire (Europe) | TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global leader in medical aesthetic technology, announced today that it has received a 510(k) clearance... ► Artikel lesen | |
| 02.10.25 | Venus Concept Inc.: Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction | 300 | GlobeNewswire (Europe) | TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on September 30... ► Artikel lesen | |
| 14.08.25 | Venus Concept Inc.: Venus Concept Announces Second Quarter 2025 Financial Results | 240 | GlobeNewswire (Europe) | TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 41,010 | -0,02 % | DAX-Rekordjagd beendet - DHL Group, Fresenius, Rheinmetall, SAP und Talanx im Check | Die Rekordjagd im DAX ist zur Wochenmitte erst einmal beendet. Gewinnmitnahmen nach dem jüngsten Hochlauf, erneute Schwäche bei KI- und Halbleiterwerten sowie schwache Vorgaben aus Asien bremsen die... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,680 | -1,70 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,280 | -1,04 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| UNITEDHEALTH | 370,40 | -0,54 % | Opening Bell: PepsiCo, AstraZeneca, UnitedHealth, Nike, Arista Networks, FuelCell Energy | Die Wall Street zeigt nach der jüngsten Eskalation im Nahen Osten bisher ein gemischtes Bild. Der Dow Jones gab gestern deutlich ab. Der Nasdaq 100 schloss dagegen leicht in der Gewinnzone, Auch heute... ► Artikel lesen | |
| THERMO FISHER | 469,40 | +0,30 % | Persistence Market Research Pvt. Ltd.: Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG | LONDON, July 8, 2026 /PRNewswire/ -- Persistence Market Research, a leading management consulting firm, has released this update on the cell culture media market. These specialized nutrient... ► Artikel lesen | |
| TELADOC HEALTH | 8,220 | +1,33 % | Teladoc (TDOC) Rises Higher Than Market: Key Facts | ||
| HIMS & HERS HEALTH | 30,860 | +0,33 % | Truist reiterates Hold on Hims and Hers stock, $23 target on peptide uncertainty | ||
| BICO GROUP | 1,272 | +2,25 % | BICO Group AB: Bulletin from the Annual General Meeting in BICO Group AB (publ) | The following resolutions were passed at the Annual General Meeting (the "AGM") of BICO Group AB (publ) ("BICO" or the "Company") held today on 7 May 2026 in Gothenburg, Sweden.
Adoption of Income Statement... ► Artikel lesen | |
| PLUS THERAPEUTICS | 3,650 | +2,38 % | Plus Therapeutics Inc.: Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide in Leptomeningeal Metastases Monitoring | HOUSTON, July 14, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), today highlighted the recent update to the National Comprehensive Cancer Network (NCCN)... ► Artikel lesen | |
| RESMED | 169,95 | +0,53 % | Health Check: Restless investors question sleep giant Resmed's short-term prospects | ||
| HEALWELL AI | 0,444 | +1,03 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,040 | +3,55 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| HENRY SCHEIN | 75,00 | -1,96 % | Henry Schein Inc. Q1 Sales Increase | MELVILLE (dpa-AFX) - Henry Schein Inc. (HSIC) reported a profit for first quarter of $107 millionThe company's bottom line came in at $107 million, or $0.92 per share. This compares with $110... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 69,68 | +0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| BILLIONTOONE | 124,59 | -0,22 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen |
VENUS CONCEPT INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,627 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENUS CONCEPT INC finden Sie auf Wallstreet Online.